Stocks News

LAST PRICE
1.9700
TODAY'S CHANGE (%)
Trending Down-0.1200 (-5.7416%)

Bid / Lots
1.9100/ 1
Ask / Lots
1.9500/ 3
Open / Previous Close
2.0900 / 2.0900
Day Range
Low 1.8901
High 2.1000
52 Week Range
Low 1.8901
High 10.4000
Volume
228,340
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Oct 31, 2024
- Evogene, Google Collaborate to Build AI Model for Small Molecule Design, from 11:26AM ET on Thursday Oct 31, 2024 by MT Newswires
  11:26AM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: GOOGL, GOOG, EVGN
  11:26 AM EDT, 10/31/2024 (MT Newswires) -- Evogene (EVGN) said Thursday that it is collaborating with Alphabet's (GOOG, GOOGL) Google Cloud to create a new foundation model for designing small molecules. The company said it will use Google Cloud's V...
- Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design, from 8:00AM ET on Thursday Oct 31, 2024 by PR Newswire
  8:00AM ET on Thursday Oct 31, 2024 by PR Newswire
  Companies Mentioned: EVGN
  The collaboration has the power to foster breakthroughs in small molecule innovation for life science-based products
  Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development, today announced a collaboration with Google Cloud to develop a cutting-edge foundation model for generative small molecule de novo design, propelling Evogene's ChemPass AI tech-engine to new levels of innovation. ChemPass AI is a computational technology platform that directs and accelerates the discovery and development of novel products based on small molecules. This groundbreaking initiative seeks to advance the discovery and development of novel small molecules for drug development, sustainable crop protection, and other innovative products across a wide range of life-science industries.
- Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design, from 8:00AM ET on Thursday Oct 31, 2024 by Dow Jones
  8:00AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: EVGN
  
  Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
  
  PR Newswire
  
  REHOVOT, Israel, Oct. 31, 2024
Oct 29, 2024
- Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya, from 8:00AM ET on Tuesday Oct 29, 2024 by PR Newswire
  8:00AM ET on Tuesday Oct 29, 2024 by PR Newswire
  Companies Mentioned: EVGN
  The shipment, comprising over 100 tons, was delivered to company's customer in Africa
  Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation solution company for oil production for bio-based products and biofuel, and a subsidiary ofEvogene Ltd.("Evogene") (Nasdaq: EVGN) (TASE: EVGN), today announced a key milestone in its operational expansion plan in Africa with the delivery of its first shipment of over 100 tons of castor seeds to its customer in Africa, seeds that were cultivated at several sites in Kenya and processed in a seed production facility near Naivasha, Kenya. The production facility started operating in August 2024 as part of Casterra's expansive operational infrastructure in Kenya.
- Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya, from 8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
  8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
  Companies Mentioned: EVGN
  
  Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya
  
  PR Newswire

Today
- Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: PSTV
Nov 1, 2024
- Plus Therapeutics Gets Additional Time to Regain Compliance With Nasdaq Listing Requirement, from 1:01PM ET on Friday Nov 01, 2024 by MT Newswires
  1:01PM ET on Friday Nov 01, 2024 by MT Newswires
  Companies Mentioned: PSTV
Oct 29, 2024
- Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas, from 7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
  7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
  Companies Mentioned: PSTV
Oct 28, 2024
- RedHill Selected to Present Opaganib at Conference Organized by U.S. Government's JPEO-CBRND, from 7:00AM ET on Monday Oct 28, 2024 by PR Newswire
  7:00AM ET on Monday Oct 28, 2024 by PR Newswire
  Companies Mentioned: RDHL
- RedHill Selected to Present Opaganib at Conference Organized by U.S. Government's JPEO-CBRND, from 7:00AM ET on Monday Oct 28, 2024 by Dow Jones
  7:00AM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: RDHL
Oct 22, 2024
- RedHill Announces Collaboration with a Leading U.S. Academic Medical Center to Develop Opaganib as a Countermeasure Against Phosgene Inhalation Injury, from 7:00AM ET on Tuesday Oct 22, 2024 by PR Newswire
  7:00AM ET on Tuesday Oct 22, 2024 by PR Newswire
  Companies Mentioned: RDHL
- RedHill Announces Collaboration with a Leading U.S. Academic Medical Center to Develop Opaganib as a Countermeasure Against Phosgene Inhalation Injury, from 7:00AM ET on Tuesday Oct 22, 2024 by Dow Jones
  7:00AM ET on Tuesday Oct 22, 2024 by Dow Jones
  Companies Mentioned: RDHL
Oct 14, 2024
- RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment, from 7:00AM ET on Monday Oct 14, 2024 by PR Newswire
  7:00AM ET on Monday Oct 14, 2024 by PR Newswire
  Companies Mentioned: RDHL
- RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment, from 7:00AM ET on Monday Oct 14, 2024 by Dow Jones
  7:00AM ET on Monday Oct 14, 2024 by Dow Jones
  Companies Mentioned: RDHL
Oct 8, 2024
- Kineta Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors, from 9:00AM ET on Tuesday Oct 08, 2024 by Dow Jones
  9:00AM ET on Tuesday Oct 08, 2024 by Dow Jones
  Companies Mentioned: KANT

Evogene Ltd
NASDAQ:EVGNUnited States

Search Criteria

Oct 31, 2024

Evogene, Google Collaborate to Build AI Model for Small Molecule Design, from 11:26AM ET on Thursday Oct 31, 2024 by MT Newswires

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design, from 8:00AM ET on Thursday Oct 31, 2024 by PR Newswire

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design, from 8:00AM ET on Thursday Oct 31, 2024 by Dow Jones

Oct 29, 2024

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya, from 8:00AM ET on Tuesday Oct 29, 2024 by PR Newswire

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya, from 8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones

Peers Headlines

Today

Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024, from 10 hours ago by Dow Jones

Nov 1, 2024

Plus Therapeutics Gets Additional Time to Regain Compliance With Nasdaq Listing Requirement, from 1:01PM ET on Friday Nov 01, 2024 by MT Newswires

Oct 29, 2024

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas, from 7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones

Oct 28, 2024

RedHill Selected to Present Opaganib at Conference Organized by U.S. Government's JPEO-CBRND, from 7:00AM ET on Monday Oct 28, 2024 by PR Newswire

RedHill Selected to Present Opaganib at Conference Organized by U.S. Government's JPEO-CBRND, from 7:00AM ET on Monday Oct 28, 2024 by Dow Jones

Oct 22, 2024

RedHill Announces Collaboration with a Leading U.S. Academic Medical Center to Develop Opaganib as a Countermeasure Against Phosgene Inhalation Injury, from 7:00AM ET on Tuesday Oct 22, 2024 by PR Newswire

RedHill Announces Collaboration with a Leading U.S. Academic Medical Center to Develop Opaganib as a Countermeasure Against Phosgene Inhalation Injury, from 7:00AM ET on Tuesday Oct 22, 2024 by Dow Jones

Oct 14, 2024

RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment, from 7:00AM ET on Monday Oct 14, 2024 by PR Newswire

RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment, from 7:00AM ET on Monday Oct 14, 2024 by Dow Jones

Oct 8, 2024

Kineta Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors, from 9:00AM ET on Tuesday Oct 08, 2024 by Dow Jones